Wanli Yang

Kleijnen Systematic Reviews (United Kingdom)

Papers

1

Total Citations

20

H-Index

1

About

Dr. Wanli Yang is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment, particularly through comparative effectiveness studies of robotic and laparoscopic gastrectomy. His major contribution lies in synthesizing high-quality evidence to resolve ongoing clinical debates about the superiority of robotic surgical systems over traditional laparoscopic approaches. His most cited work, a 2024 systematic review and meta-analysis examining efficacy and safety outcomes between these two modalities, has already garnered 20 citations, reflecting its immediate impact on surgical decision-making. This comprehensive analysis addressed critical gaps in understanding whether robotic gastrectomy offers meaningful advantages in perioperative outcomes and long-term survival for gastric cancer patients. Dr. Yang’s research is notable for its rigorous methodological approach to evidence synthesis, providing surgeons with data-driven insights to optimize patient care. His work continues to shape clinical practice guidelines and inform the adoption of advanced surgical technologies in oncology, making him a respected voice in the evolving field of robotic-assisted cancer surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Efficacy and safety of robotic vs. laparoscopic gastrectomy for patients with gastric cancer: systematic review and meta-analysis
20 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Kleijnen Systematic Reviews (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago